Forward-thinking priorities were established in the High-Tech Agenda Germany published by the BMFTR on May 21, 2026. The LPI is included in the agenda as an active part of the implementation structure.
The Federal Ministry of Research, Technology and Space (BMFTR) has released its roadmaps for implementing the High-Tech Agenda Germany (HTAD). The goal of the HTAD is to pool strengths, bolster Germany’s innovative capacity, and accelerate the transition from research to application. The agenda is intended as a guide for active implementation. It focuses on six key technologies: Artificial Intelligence, Quantum Technologies, Microelectronics, Biotechnology, Fusion, and Battery Technology.
Within the Technology Roadmap for Biotechnology, the LPI is part of the Health Research target area. Specifically, the LPI is listed as the implementation partner for the milestone Technology-driven translation infrastructure for infection medicine, with the First-in-Patient Unit (FiPU) at the Jena University Hospital serving as the target for bedside technology testing.This not only increases the visibility of the LPI itself but also enhances Thuringia’s profile as a hub for innovation.
Infectious diseases are a critical area in predictive and preventive medicine, healthcare, and crisis preparedness. With increasing antibiotic resistances, there is a need for novel approaches for diagnostics and personalized treatment. The LPI addresses this need and helps position photonic infection research as a key technology field, combining photonics with artificial intelligence, biotechnology, medical technology, and clinical expertise within a clinically relevant environment.
